Hair Growth Promotion by δ-Opioid Receptor Activation
10.4062/biomolther.2021.064
- Author:
Mei ZHENG
1
;
Nahyun CHOI
;
Gianfranco BALBONI
;
Ying XIA
;
Jong-Hyuk SUNG
Author Information
1. STEMORE Co. Ltd., Incheon 21983, Republic of Korea
- Publication Type:Original Article
- From:Biomolecules & Therapeutics
2021;29(6):643-649
- CountryRepublic of Korea
- Language:English
-
Abstract:
Literature has revealed that the delta opioid receptor (DOR) exhibited diverse pharmacological effects on neuron and skin. In the present study, we have investigated whether the activation of DOR has hair-growth promotion effects. Compared with other opioid receptor, DOR was highly expressed in epidermal component of hair follicle in human and rodents. The expression of DOR was high in the anagen phase, but it was low in the catagen and telogen phases during mouse hair cycle. Topical application of UFP-512, a specific DOR agonist, significantly accelerated the induction of the anagen in C 3H mice. Topical application of UFP-512 also increased the hair length in hair organ cultures and promoted the proliferation and the migration of outer root sheath (ORS) cells. Similarly, pharmacological inhibition of DOR by naltrindole significantly inhibited the anagen transition process and decreased hair length in hair organ cultures. Thus, we further examined whether Wnt/β-catenin pathway was related to the effects of DOR on hair growth. We found that Wnt/β-catenin pathway was activated by UFP-512 and siRNA for β-catenin attenuated the UFP-512 induced proliferation and migration of ORS cells. Collectively, result established that DOR was involved in hair cycle regulation, and that DOR agonists such as UFP-512 should be developed for novel hair-loss treatment.
